MG
SNY icon

Michael Gelband’s Sanofi SNY Stock Holding History

Michael Gelband’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-19,257
Closed -$936K – 2565
2020
Q4 		$936K Sell
19,257
-37,121
-66% -$1.83M 0.01% 888
2020
Q3 		$2.83M Buy
56,378
+24,397
+76% +$1.26M 0.06% 293
2020
Q2 		$1.63M Buy
+31,981
New +$1.55M 0.04% 514
2019
Q4 		– Sell
-16,057
Closed -$744K – 1858
2019
Q3 		$744K Buy
+16,057
New +$692K 0.03% 489
2019
Q2 		– Sell
-7,757
Closed -$343K – 1308
2019
Q1 		$343K Buy
+7,757
New +$332K 0.03% 429

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Michael Gelband's SNY Position: Q1 2021 in Review

Michael Gelband sold out of Sanofi (SNY) in Q1 2021, closing a stake of 19,257 shares — an estimated $936K sold.

Michael Gelband first reported a position in SNY in Q1 2019 and held it in 5 quarters. The position peaked at $2.83M in Q3 2020. 573 funds tracked by Wall St. Rank hold SNY as of Q1 2021.

  • Michael Gelband reported no remaining Sanofi position as of Q1 2021 after selling out during the quarter.
  • Michael Gelband sold 19,257 Sanofi shares in Q1 2021, an estimated $936K.
  • Michael Gelband first reported a position in Sanofi in Q1 2019 and held it in 5 quarters.
  • Michael Gelband's Sanofi position peaked at $2.83M in Q3 2020.
  • 573 funds tracked by Wall St. Rank held Sanofi as of Q1 2021.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.